Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

232
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
232
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

253
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
253
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

285
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
285
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

169
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
169
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

179
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
179

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Personalizing Chronic Oxygen Prescriptions-Going Beyond P<sub>aO<sub>2</sub></sub> Targeting.

Respiratory care·2025
Same author

Translating Pulmonary Function Test Results into Practical Clinical Interpretations.

Annals of the American Thoracic Society·2025
Same author

It Takes a Village-Evolving Role for Dedicated Teams for COPD Management.

Respiratory care·2025
Same author

A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease.

JAMA·2025
Same author

Risk of Atherosclerotic Cardiovascular Disease After Chronic Obstructive Pulmonary Disease Hospitalization among Primary and Secondary Prevention Older Adults.

Journal of the American Heart Association·2025
Same author

Author Response: Let It Breathe: Mastering Spontaneous Breathing Trials.

Respiratory care·2024

相关实验视频

Updated: Jul 25, 2025

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

749

在COPD中急性超性呼吸衰竭

Neil R MacIntyre1

  • 1Duke University Medical Center, Durham, North Carolina. neil.macintyre@duke.edu.

Respiratory care
|June 23, 2023
PubMed
概括

慢性阻塞性肺病 (COPD) 恶化包括肺炎的急性恶化,往往导致呼吸衰竭. 治疗包括药物和呼吸系统支持,未来的战略是探索体外技术.

科学领域:

  • 肺部病理学 肺部病理学
  • 临界护理医学 临界护理医学

背景情况:

  • 慢性阻塞性肺病 (COPD) 是一种进展性炎症性肺病.
  • 恶化代表了急性恶化,经常是由感染引发的.
  • 严重的恶化可能会导致由于空气捕获和肌肉过载而导致高气呼吸衰竭.

研究的目的:

  • 审查严重的COPD恶化的管理.
  • 讨论当前和未来的呼吸系统生命支持策略.

主要方法:

  • 对COPD恶化症的药理疗法和呼吸系统辅助技术的文献综述.
  • 讨论侵入性和非侵入性通风,以及体外生命支持.

主要成果:

  • 药理疗法包括支气管扩展剂,皮质类固醇和抗生素.
  • 呼吸系统的支持范围从氧气治疗到正压通风.
  • 身体外生命支持是潜在的未来战略.

结论:

  • 严重的COPD恶化症的管理需要采用多方面的方法.
  • 当前的生命支持技术对于急性呼吸衰竭至关重要.
  • 体外技术的进步可能会提供新的治疗选择.
关键词:
慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.复发性慢性肺炎的恶化空气陷 (内在的PEEP)超气性呼吸衰竭是指高气性呼吸衰竭.吸入肌肉过度负荷的情况积极压力通风 (侵入性和非侵入性)

更多相关视频

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.5K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD &#8212; A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

836

相关实验视频

Last Updated: Jul 25, 2025

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

749
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.5K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD &#8212; A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

836